Compare TWST & EXLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TWST | EXLS |
|---|---|---|
| Founded | 2013 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 4.3B |
| IPO Year | 2018 | 2004 |
| Metric | TWST | EXLS |
|---|---|---|
| Price | $91.19 | $27.68 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 5 |
| Target Price | ★ $46.88 | $46.80 |
| AVG Volume (30 Days) | 1.5M | ★ 2.3M |
| Earning Date | 05-04-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 63.89 | 27.27 |
| EPS | N/A | ★ 0.43 |
| Revenue | ★ $376,572,000.00 | N/A |
| Revenue This Year | $18.91 | $12.61 |
| Revenue Next Year | $15.07 | $10.55 |
| P/E Ratio | ★ N/A | $62.51 |
| Revenue Growth | ★ 20.32 | N/A |
| 52 Week Low | $23.30 | $24.85 |
| 52 Week High | $105.47 | $47.08 |
| Indicator | TWST | EXLS |
|---|---|---|
| Relative Strength Index (RSI) | 52.65 | 50.87 |
| Support Level | $86.30 | $26.88 |
| Resistance Level | $105.47 | $29.07 |
| Average True Range (ATR) | 6.31 | 0.90 |
| MACD | -1.21 | 0.05 |
| Stochastic Oscillator | 38.28 | 53.17 |
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.
ExlService Holdings Inc. is a data analytics and digital operations company that provides data and AI-led solutions and technology-enabled services to clients across industries. The company has four reportable segments. The Insurance segment provides services such as claims management, underwriting support, and analytics solutions. The Healthcare and Life Sciences segment offers data-driven solutions and services to healthcare payers, providers, and life sciences organizations. The Banking, Capital Markets and Diversified Industries segment delivers solutions across financial services and other industries. The International Growth Markets segment focuses on providing data, AI, and digital operations services to clients outside North America.